Lysodren 500mg is a cancer medicine used to treat certain types of cancer, specifically adrenocortical carcinoma (a type of cancer that starts in the outer layer of the adrenal gland). It works as a anti cancer agent by destroying the cells in the outer layer of the adrenal gland, which are the cells that are most likely to become cancerous. 

Lysodren (mitotane) is a cytostatica that is used to treat certain types of cancer, specifically adrenocortical carcinoma and certain types of breast cancer. It works by inhibiting the growth and division of cancer cells, which ultimately leads to the death of the cells.

Lysodren (mitotane) is usually taken as a single daily dose, but the specific dosage will be determined by a healthcare provider based on the patient's specific needs. Normal incidental effects incorporate sickness, retching, looseness of the bowels, and loss of craving. It is important to note that Lysodren(antineoplastic medication) can cause serious side effects, including damage to the liver and kidneys, so it should only be taken under the close supervision of a doctor.

Lysodren is considered as an antitumoral medication different from most cytotoxic drugs in that it is specific to adrenal cancer cells, thus it has less general toxicity on the body. It is usually used in combination with other cancer treatments and close monitoring by a healthcare provider is needed as it can cause significant side effects.

Lysodren is not typically used to treat anaplastic lymphoma kinase (ALK) positive cancer. ALK positive cancer is a subtype of non-small cell lung cancer (NSCLC) that is characterized by a genetic alteration in the ALK gene. The ALK gene provides instructions for making a protein called anaplastic lymphoma kinase, which plays a role in cell growth and division. ALK positive cancer is treated with specific ALK inhibitors, such as crizotinib and ceritinib, which target and inhibit the activity of the ALK protein.